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plasticity was studied. Rats injected with 8-OH-DPAt 
exhibited a significant reduction in MDA and epileptic 
discharges, a decrease in paired-pulse facilitation and an 
increase in long-term potentiation. this study suggests that 
8-OH-DPAt or in general 5-Ht1A/7 agonists might be use-
ful for the treatment of tLE and also have some beneficial 
effects on the comorbid cognitive disorders seen in epilep-
tic patients.
Keywords temporal lobe epilepsy · Dentate 
gyrus · Serotonin receptors · Memory · Depression · 
Serotonergic1A drugs
Introduction
Alterations in serotonin (5-Ht) neurochemistry have 
been implicated in the aetiology of all major cerebral 
disorders, ranging from schizophrenia to mood and anx-
iety-spectrum disorders including epilepsy (Di Giovanni 
et al. 2008; Bombardi and Di Giovanni 2013; Bortolato 
et al. 2013). Moreover, a dysfunctional serotonergic sys-
tem might be responsible for the occurrence of concomi-
tant diseases such as temporal lobe epilepsy (tLE) and 
comorbid depression and cognitive impairments and 
depression (Kanner and Balabanov 2002; Garcia 2012; 
theodore et al. 2012). Among the different 5-Ht recep-
tor (R) subtypes, compelling pre-clinical and human 
studies have indicated an impairment of 5-Ht1A signal 
in tLE and comorbid psychiatric disorders seen in these 
patients (theodore et al. 2012). Indeed, recent imaging 
studies have shown a reduced serotonin 5-Ht1AR binding 
in the temporal cortex and hippocampus of tLE patients 
(Giovacchini et al. 2005). nonetheless, the 5-Ht1A system 
is complex, and the effects of its activation are far from 
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being completely characterized; moreover, the experimen-
tal results hitherto obtained are controversial. the picture 
is complicated further as central 5-Ht1ARs are both auto-
receptors in 5-Ht nuclei and post-synaptic receptors in 
terminal field areas (Pazos and Palacios 1985), with dif-
ferent functional and regulatory characteristics, depending 
on the structures innervated (Jolas et al. 1995). Serotoner-
gic projections to the hippocampus arise from the dorsal 
and median raphe nucleus (DRn and MRn), and prefer-
entially innervate GABAergic interneurons although they 
are present also on principal cells (Freund et al. 1990; 
Freund 1992). Earlier in vivo studies reported that 5-Ht 
releasers facilitate the response of dentate granule (DG) 
cells to perforant path (PP) stimulation (Richter-Levin 
and Segal 1990), an effect that is thought to be mediated 
by hippocampal post-synaptic 5-Ht1ARs (Levkovitz and 
Segal 1997) on GABAergic interneurons and consequent 
inhibition of GABA release (Freund et al. 1990; Freund 
1992; Gulyas et al. 1999). Consistently, 5-Ht1ARs in the 
DG exert an excitatory effect that plays a permissive role 
in long-term potentiation (LtP) induction, particularly 
in environments with a high degree of novelty (Sanberg 
et al. 2006). Opposite results on DG excitability have 
been obtained with systemic administration of low doses 
of (+)-8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-
DPAt) (Klancnik et al. 1989; Sanberg et al. 2006), a mixed 
5-Ht1A/7 agonist, likely due to the preferential activation 
of the somatodendritic 5-Ht1ARs in the raphe versus the 
post-synaptic 5-Ht1ARs that would result in hippocampal 
5-Ht release decrease (Sharp and Hjorth 1990; Lacivita 
et al. 2008). nevertheless, the involvement of 5-Ht7Rs 
in PP-DG synapse cannot be ruled out, considering new 
evidence of their involvement in CA3-CA1 hippocampal 
plasticity (Costa et al. 2012a, b). As far the 8-OH-DPAt 
anticonvulsant effect is concerned, it is noteworthy that 
only high doses of the drug are effective in various tLE 
experimental models, such as in vivo and in vitro hip-
pocampal seizure models (theodore 2003; Lopez-Meraz 
et al. 2005) and kainic acid (KA)- and pentylenetetrazol 
(PtZ)-induced status epilepticus (SE) (Lopez-Meraz et al. 
2005, 2007). Scanty results exist instead of the effect of 
8-OH-DPAt on DG hyperexcitability, for instance, in the 
DG kindling model, systemic activation of 5-Ht1A pro-
duced no epileptic effect (Cagnotto et al. 1998; Watanabe 
et al. 1998). therefore, there is enough evidence to sug-
gest the use of 5-Ht1A agonists for the treatment of tLE. 
noticeably, the effect of the anticonvulsant high dose of 
5-Ht1A agonists on the synaptic plasticity of hippocam-
pal cells under normal conditions has not yet been inves-
tigated. this evidence is very important in the light of the 
comorbid cognitive impairment seen in epileptic patients 
and the deleterious effects of conventional antiepileptic 
drugs (AEDs) on memory (Motamedi and Meador 2004).
With the aim of filling this gap, we performed the pre-
sent in vivo electrophysiological studies to evaluate the 
effects of the systemic administration of a high dose of 
8-OH-DPAt (1 mg/kg, i.p.) on the reactivity of dorsal hip-
pocampal granular cells under hyper- and normal excit-
able conditions following PP stimulating paradigms in 
urethane anesthetized rat. to this end, we used two differ-
ent tetanic high-frequency stimulation (HFS) protocols to 
induce either the phenomenon of maximal dentate activa-
tion (MDA, 20 Hz), a model of partial complex (limbic) 
seizures, or long-term potentiation (LtP, 200 Hz) at PP-DG 
synapses. Single or paired-pulse stimulations delivered to 
PP fibres were instead used (1) to evaluate dentate evoked 
field potential (i.e. the field excitatory post-synaptic poten-
tial (fEPSP) slope and population spike (pSpike) ampli-
tude), (2) to produce input/output curves (100–1,000 μA) 
and (3) to compute the paired-pulse index (PPI) for paired-
pulse stimulation ranging from 20 to 600 ms. Our results 
by supporting previous work further suggest that 5-Ht1ARs 
are potential therapeutic targets for the treatment of tLE 
seizures and also show a potential benefit for the comor-
bid cognitive impairment seen in patients with this form of 
epilepsy.
Methods and methods
Surgical procedures
the care and treatment of all animals conformed to Council 
Directive 86/609/EEC and with the Animals Scientific Pro-
cedures Act 1986, and local regulations for the care and use 
of animals in research. All efforts were taken to minimize 
the animals’ pain and suffering and to reduce the number of 
animals used.
Experiments were conducted on male Sprague–Dawley 
rats weighing ~300 g from Charles River Laboratories UK, 
which were anesthetized by i.p. urethane (Sigma-Aldrich 
Co., Milano, Italy) (1.2 g/kg) administration and positioned 
in a David Kopf stereotaxic frame. Body temperature was 
maintained by a heating pad and a temperature controller 
unit (temperature Control Unit HB 101/2, Letica Scientific 
Instruments).
Field potentials were evoked by stimulating the PP (AP: 
−8.3 L: 4.8 V: 3.4) (Paxinos and Watson 1986) with a 
bipolar stimulating electrode (bifilar twisted stainless steel, 
Stainless Steel Wire AISI316, Advent). the recording 
electrode (tungsten Low Resistance Electrode, A-M Sys-
tems Inc., Carlsborg USA) was implanted into the hilus 
of the DG of the hippocampus (AP: −4.8 L: 2.2 V: 3.6) 
(Paxinos and Watson 1986). During the surgical procedure, 
electrodes were advanced slowly downward until reach-
ing the optimal depth to record PSs. In order to record 
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during implantation and experiment, a neuroLog ampli-
fier (Digitimer Ltd, high pass: 0.2 Hz, low pass: 5,000 Hz, 
gain: 200) was used. Using a constant current stimulator 
(Digitimer Ltd, model DS3), digitally controlled stimula-
tor, square-wave pulses of 0.2 ms duration were applied, 
1 per minute. Stimulus intensity was set to evoke 60–70 % 
of the maximum amplitude of the pSpike. After the opti-
mal depth to record pSpike had been reached, control data 
were acquired after a 30 min delay to allow the tissue to 
recover from any trauma due to electrode implantation. 
the same recording and stimulation procedure were used 
as under implantation.
Recording of pSpike was performed using the same set-
tings as during implantation (see above). Responses were 
digitized by a CED 1401 plus analogue–digital converter 
(Cambridge Electronic Design Ltd., Cambridge, UK), 
stored on a computer and averaged offline using Signal 1.9 
software. Sampling rate was set to 10 kHz. Location of the 
recording electrode was verified histologically.
Maximal dentate activation experiments
Maximal dentate activation (MDA) was characterized 
electrophysiologically by (1) the onset of large-amplitude 
pSpikes (i.e. 20–40 mV) fired in bursts and (2) a rapid 
negative DC shift in baseline of DG electrical recordings 
(Stringer et al. 1989). Stimulus trains of 10 s (pulses of 
0.3 ms duration, at 20 Hz) were delivered through the 
PP electrode at an initial intensity of 200 μA. If MDA 
was not elicited, the stimulus intensity was increased 
in 50 μA steps and redelivered every 2.5 min until 
MDA was induced. Usually, threshold was reached at 
350 ± 100 μA, and then stimulus intensity was further 
increased by 100 μA. For each stimulus, the duration of 
MDA, time to onset and AD were measured as shown in 
Fig. 1a.
time to onset and duration of MDA were measured 
as repeated seizure-inducing trains were delivered every 
10 min for the next 4 h (total of 24 stimulus trains). As 
shown in Fig. 1a, the latency to MDA onset was measured 
from stimulus onset to the point of pSpike appearance with 
half of the maximal amplitude.
After the AD had begun to lengthen, either drug or 
vehicle was administered just after the fifth stimulus train. 
In the absence of drug, the duration of maximal dentate 
activation will increase and the time to onset will gradu-
ally decrease (Stringer and Lothman 1990a). In order to 
make comparisons across animals, the measured durations 
of MDA and time to onset were ‘normalized’ by subtract-
ing their duration in response to the first stimulus from the 
duration in response to each subsequent stimulus train. 
thus, for individual stimulus trains after the first, a change 
in duration (or time to onset) was calculated. In this way, 
data from separate animals were averaged and compari-
sons across groups of animals were made (Stringer and 
Lothman 1990a).
Fig. 1  Effect of 8-OH-DPAt on 
MDA and after discharge (AD) 
duration recorded in AC mode. 
a MDA is not prolonged in 
8-OH-DPAt (1 mg/kg; n = 5) 
treated animals as compared 
with saline control rats (n = 9) 
after 14 repetitive seizure-
inducing stimuli (b)
A
B
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time course of the drugs
After the 30 min recovery (as mentioned above), a 
60 min baseline was recorded for each experiment. 
5 sweeps of each different interval were averaged. A 
30 s gap was kept between the sweeps. the average of 
these sweeps served as the control pSpike and fEPSP, 
and their amplitude and slope were expressed as a per-
centage of these control values. Following the baseline 
recording, drug was administered, and its effect recorded 
for 120 min.
I/O recordings
the recordings were started after the post-surgical recovery 
period when single pulses were applied with different pulse 
strengths (100–1,000 μA in 100 μA steps). 5 sweeps of 
each different pulse strength were averaged. A 30 s gap was 
maintained between the sweeps. Results were evaluated 
by plotting pSpike amplitude and fEPSP slope against the 
stimulus strength, and also by plotting amplitude against 
the fEPSP slope (I/O curves). these curves were repeated 
30 min after the 8-OH-DPAt systemic injection (treatment 
curves) and compared with those obtained in the pre-drug 
period.
Paired-pulse recordings
In these experiments after the recovery, pairs of identical 
pulses were applied with different interpulse intervals (IPI) 
(20, 25, 40, 110, 150, 600 ms). 5 sweeps of each different 
interval were averaged. A 30 s gap was maintained between 
the sweeps. the paired-pulse ratio (PPR) of the pSpike 
amplitudes of the 1st (conditioning pulse) and 2nd (test 
pulse) responses was assessed in control (pre-drug) and 
treatment (post drug) conditions. Since the time course of 
the drug effects showed a peak effect reached 30 min after 
administration, the effect of 8-OH-DPAt was evaluated 
30 min after its administration.
LtP recordings
After 30 min of post-surgical recovery, single pulses were 
applied. 1 pulse was applied every 60 s, and 5 responses 
were averaged. Pulse strength was set to evoke 30 % of 
the maximum pSpike amplitude. After a 10 min baseline, 
either vehicle or 8-OH-DPAt was administered i.p. the 
effect of the treatments on the baseline was observed for 
30 min, and then a high-frequency pulse train (HFS) was 
applied (same pulse parameters as in baseline, 10 trains 
of 15 pulses at 200 Hz, with 1 s delay between trains) to 
evoke LtP.
Statistical analysis
Evaluation of the recorded data was conducted using 
Spike2 software (CED, Cambridge, UK). One-way analy-
sis of variance (AnOVA) for repeated measures followed 
by Fisher’s PLSD post hoc test was used. Differences were 
considered significant at p < 0.05.
Results
Effect of 8-OH-DPAt on the parameters of maximal 
dentate activation
the effect of administration of the vehicle (saline) on 
the time to onset and duration of MDA was determined 
in nine animals. there was an increase in the change of 
duration of MDA over the first 14 stimuli (Figs. 1, 2), 
and it then became quite variable reaching 24.5 ± 2.4 s 
after the 24th stimulus (Fig. 2a). there was also a grad-
ual decrease in the time to onset to −2.2 ± 0.3 (at the 
8th stimulus) and then a plateau (Fig. 2b). the typical 
effect of 8-OH-DPAt (1 mg/kg, i.p.; n = 5) treatment on 
the MDA is shown on the sample traces of Fig. 1. the 
increase in the duration of the MDA (Fig. 2a) was signifi-
cantly blocked by 8-OH-DPAt 20 min after its systemic 
administration (8-OH-DPAt vs. vehicle, 8.6 ± 0.9 vs. 
3.6 ± 1.5; F1,12 = 7.893, p < 0.05) for the entire dura-
tion of the experiment, reaching the maximum effect at 
the 19th stimulation (8-OH-DPAt vs. vehicle 13.6 ± 5.0 
vs. 1.1 ± 2.6). the effect of 8-OH-DPAt on the change 
in AD followed a similar pattern to the effect of the drug 
on MDA elongation (not shown). On the other hand, the 
latency of the onset of MDA (Fig. 1b) was not affected 
by the 8-OH-DPAt treatment, although a not signifi-
cant decrease was seen 30 min after the drug injection 
(8-OH-DPAt vs. vehicle: −1.5 ± 0.6 vs. −2.2 ± 0.3; 
F1,12 = 0.087, p = 0.77).
time course
Systemic administration of 8-OH-DPAt (1 mg/kg, i.p.; 
n = 3) produced a significant increase in both the slope of 
the fEPSP and the amplitude of the pSpikes which attained 
a maximum of 121.1 ± 1.8 % (8-OH-DPAt vs. vehi-
cle; F1,6 = 17.685, p < 0.01) and 121.5 ± 3.0 % (8-OH-
DPAt vs. vehicle; F1,6 = 5.456, p < 0.05) of baseline 
values (Fig. 3a, b), respectively, when compared with the 
vehicle group (saline, n = 5). these effects appeared after 
10 min and remained significant for the entire duration of 
the recording for the slope of fEPSP and in different time 
points for pSpike amplitude (Fig. 3a, b).
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I/O experiments
In these experiments, the stimulus strength was changed 
in 100 μA steps starting from 100 μA. A series of sample 
traces is shown in control condition and after 8-OH-DPAt 
treatment (Fig. 4a). to evaluate how the input/output rela-
tion of the DG cells is affected by the drug, the amplitude 
of pSpike and the slope of the fEPSP were plotted against 
each stimulus strength (Fig. 4b). no statistically significant 
changes were observed (8-OH-DPAt vs. control; pSpikes 
F1,13 = 0.617, p = 0.45; slope fEPSP, F1,13 = 0.118, 
p = 0.74; n = 5), although 8-OH-DPAt affected the pSpike 
amplitudes more (decreasing it) than fEPSP slopes.
Paired-pulse experiments
Pairs of pulses with identical pulse parameters were applied 
to the PP with different IPIs. the intervals were the fol-
lowing: 20, 25, 40, 110, 150 and 600 ms. In control condi-
tions (pre-drug), the pulse intervals of 20 and 25 ms length 
caused a decrease in the second response (early inhibition), 
the 40, 110 and 150 ms intervals caused facilitation of the 
responses, while the 600 ms delay caused a decrease in the 
second response (late inhibition).
Sample traces for control and 8-OH-DPAt are shown 
at 3 different interpulse intervals (Fig. 5 insets). the PPR 
between the pSpike amplitudes of the first and second 
response is plotted against IPIs in control and after 8-OH-
DPAt administration in Fig. 5. the inhibitory interac-
tions were not altered by the 8-OH-DPAt treatment, while 
-3
-2
-1
0
1
Ch
an
ge
 in
 ti
m
e 
to
 o
ns
et
 o
f M
DA
 (s
ec
)
Number of stimuli
0
5
10
15
20
25
30
In
cr
ea
se
s 
in
 d
ur
at
io
n 
of
 M
DA
 (s
ec
)
control 8-OH-DPAT
*
**
**
*
*
**
**
* *
*
A
B
Fig. 2  Effect of 8-OH-DPAt on the parameters of MDA. the dura-
tion and time to onset of MDA were measured for each stimulus 
train. these values were then normalized, averaged and plotted 
(±SEM) against stimulus number. 8-OH-DPAt was administered i.p. 
at the arrow. the open squares line indicates the mean values from 
the vehicle control animals. a the effect of 8-OH-DPAt at 1 mg/
kg (n = 5, filled squares) and vehicle (n = 9, empty squares) on the 
change in duration of MDA. b the effect of 8-OH-DPAt at 1 mg/
kg (n = 5, filled squares) and vehicle (n = 9, empty squares) on the 
change in the time to onset of MDA. One-way AnOVA for repeated 
measures followed by Fisher’s PLSD post hoc test; 8-OH-DPAt ver-
sus vehicle group, *p < 0.05, **p < 0.01
80
85
90
95
100
105
110
115
120
125
130
pS
pi
ke
 A
m
pl
itu
de
 (%
 of
 ba
se
lin
e) 
Time (min)
80
85
90
95
100
105
110
115
120
125
130
fE
PS
P 
Sl
op
e 
(%
 of
 ba
se
lin
e) 
Vehicle 8-OH-DPAT
A
B
*
**
**
****
****
******
****
****
**
*
*
**
*
***
*
*
**
**
*
*
*
**
**
Fig. 3  Effects of peripheral administration of 8-OH-DPAt on pSpike 
response of dentate granular cells to perforant path stimulation. 
Empty squares saline (n = 5); filled squares 8-OH-DPAt (1 mg/kg, 
i.p; n = 3). Drugs were injected i.p. at time = 0. Each point the 
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slope and in b on pSpike amplitude versus the vehicle group. One-
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hoc test; 8-OH-DPAt versus vehicle group, *p < 0.05, **p < 0.01
 Exp Brain Res
1 3
facilitation at 40 and 110 ms was significantly affected by 
the drug (8-OH-DPAt vs. control, one-way AnOVA for 
repeated measures, interaction treatment x stimulus inter-
val, F5,35 = 5.879, p < 0.01; n = 5).
LtP
the 8-OH-DPAt administration significantly increased both 
the amplitude of the pSpike (123.9 ± 8.1 % after 25 min, 
8-OH-DPAt vs. vehicle, F1,7 = 10.874, p < 0.05; n = 5) and 
the slope of the fEPSP (122.3 ± 3.1 % after 20 min, 8-OH-
DPAt vs. vehicle F1,7 = 193.707, p < 0.01; n = 5) compared 
to the vehicle group (n = 5) (Fig. 6), similarly to the results 
that we obtained in the time courses experiments. According 
to well-established findings (Bliss and Lomo 1973), HFS 
induced LtP for fEPSP slope and pSpike amplitude of the 
vehicle group, these changes were followed up to 120 min 
(Fig. 6b, c). to evaluate the effect of 8-OH-DPAt treat-
ment on the LtP without confounding effects, we subtracted 
the drug pre-stimulation value from the post-tetanic ones 
and we still observed a significant increase in fEPSP slope 
(8-OH-DPAt vs. vehicle, F1,8 = 7.207, p < 0.05) but not in 
the pSpike amplitudes (F1,8 = 0.467, p = 0.51) when they 
were compared to the vehicle group (Fig. 6b, c).
Discussion
to our knowledge, the present electrophysiological study 
is the first in vivo investigation of the effects of acute 
treatment of 8-OH-DPAt, at a dose (1 mg/kg, i.p.) that has 
been shown to have an anticonvulsant effect (Salgado and 
Alkadhi 1995; Gariboldi et al. 1996; Salgado-Commissar-
iat and Alkadhi 1997; tokarski et al. 2002; Lopez-Meraz 
et al. 2005, 2007), on granular cell reactivity and short- and 
long-term plasticity.
We used 8-OH-DPAt as it is a potent 5-Ht1AR ago-
nist that has been widely used to study the function of this 
5-HtR subtype (Lacivita et al. 2008) although it has been 
shown to act as a 5-Ht7R agonist as well (Lovenberg et al. 
1993). the DG was chosen as it plays an important role in 
hippocampal excitability, epileptogenesis, memory pro-
cessing and depression [see for recent reviews the volume 
edited by (Scharfman 2007)]. Indeed, the DG is commonly 
considered to be a gate that prevents excessive activity 
from entering other hippocampal regions (Heinemann 
et al. 1992). the breakdown of this gate, with activation 
of DG cells, could be a critical event in the development 
of seizure activity within the temporal lobe (Collins et al. 
1983; Heinemann et al. 1992). Support for this idea in 
vivo has come primarily from studies of acutely induced 
seizures by PP stimulation in which maximal activation 
of the DG occurs and the rate of increase in its duration 
has been described as a paradigm analogous to electri-
cal kindling (Stringer et al. 1989; Stringer and Sowell 
1994). Although this animal model has been extensively 
used to screen compounds for activity against limbic sei-
zures (Stringer and Lothman 1990a) or neuromodulators 
(Stringer and Erden 1995) or more recently for the effect 
of ketogenic diet (Bough et al. 2003), the antiepileptogenic 
Fig. 4  Effects of peripheral 
administration of 8-OH-DPAt 
on pSpike response of dentate 
granular cells to perforant path 
stimulation with increasing 
stimulation strength. Input–
output (I/O) responses were 
obtained by assessing the ampli-
tude of the pSpike to stimula-
tion intensities of 100 through 
1,000 μA. a Cartoon showing 
pSpikes for pre-drug condition 
(control) and after administra-
tion of 8-OH-DPAt to stimula-
tion intensities. b Input–output 
plots revealed a non-significant 
decrease in pSpike amplitude 
and no change of fEPSP slope 
produced by 8-OH-DPAt 
(n = 5; 1 mg/kg, i.p.) versus 
control values as the stimulation 
strengths were increased. Stim-
uli of 100–1,000 μA (0.1-ms 
duration) consistently evoked 
pSpikes that were 60–80 % of 
plateau responses
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and anticonvulsant role of 5-Ht and/or its receptors sub-
types has not been investigated yet. the only available 
electrophysiological studies of 8-OH-DPAt on DG hyper-
excitability have been performed in kindled rats in chronic 
conditions (Cagnotto et al. 1998; Watanabe et al. 1998), 
both indicating a lack of effect of 8-OH-DPAt on kindling 
progression (Cagnotto et al. 1998) and on any other sei-
zure parameters (Watanabe et al. 1998). therefore, these 
data suggest that 5-Ht1ARs may be involved in the fine 
modulation of hippocampal excitability, acting in concert 
with other neurotransmitter systems, and their activation 
alone may not be sufficient to interfere with the epilepto-
genic process in rats. nevertheless, a lasting and selective 
increase in 5-Ht1AR density induced by kindling has been 
shown in rats, likely due to an adaptive response of granule 
cells to recurrent epileptic activity that might contribute to 
modulation of DG hyperexcitability (Cagnotto et al. 1998).
Opposite results have been obtained in cats, where 
8-OH-DPAt increases the AD threshold, reduces the 
duration of partial seizures and avoids generalized sei-
zures induced by hippocampal kindling (Wada et al. 
1992, 1993). In agreement with this evidence, activation 
of 5-Ht1ARs reduces the EEG hippocampal epileptiform 
activity when induced in vitro (Salgado and Alkadhi 1995; 
0
1
2
20 25 40 11
0
15
0
60
0
Stimulus interval (msec)
PS
2/
PS
1 
Ra
tio
Control
8-OH-DPAT
5 msec
10
 m
V
*
*
Fig. 5  Effects of peripheral administration of 8-OH-DPAt on paired-
pulse relationship in the dentate gyrus. the responses in the dentate 
gyrus after paired stimulations 20, 25, 40, 110, 150 and 600 ms apart 
are shown for the pre-drug condition (control) and after administra-
tion of 1 mg/kg 8-OH-DPAt. the ratio of the amplitude of the pSpike 
in response to the second stimulus (PS2) is divided by the amplitude 
of the pSpike in response to the first stimulus (PS1) to give an inhibi-
tion ratio. If the ratio is 1, this indicates that there is no inhibition 
and the two pSpikes have the same amplitude. Ratios less than one 
indicate some degree of inhibition of the second pSpike. On the other 
hand, ratios more than one indicate facilitation of the second pSpike. 
the graph represents the mean (n = 5, ±SEM) ratios at each inter-
pulse interval before (control) and after administration of 1 mg/kg, 
i.p. of 8-OH-DPAt. After administration of 8-OH-DPAt the response 
to the second stimulus at the 40 and 110 ms interpulse interval is 
about 50 % of the response to the first stimulus, indicating a loss of 
facilitation (sample field potentials in control and 8-OH-DPAt). One-
way AnOVA for repeated measures followed by Fisher’s PLSD post 
hoc test; 8-OH-DPAt versus control group, *p < 0.05
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Fig. 6  Changes in LtP after 8-OH-DPAt in the perforant path-den-
tate gyrus synapses. a Sample field potentials in vehicle (n = 5) and 
8-OH-DPAt (n = 5) treated rats at the baseline (1), after drug treat-
ment (2) and HSF (3) time. b time course changes of the slope of 
fEPSP before and after HSF-induce LtP in the 8-OH-DPAt and vehi-
cle group. c time course changes of the amplitude of pSpike before 
and after HSF-induce LtP in the 8-OH-DPAt and vehicle group. 
Drugs were injected i.p. at the arrow. One-way AnOVA for repeated 
measures followed by Fisher’s PLSD post hoc test; 8-OH-DPAt ver-
sus vehicle group, *p < 0.05, **p < 0.01
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Salgado-Commissariat and Alkadhi 1997) and in vivo 
by different pharmacological models of tLE (Gariboldi 
et al. 1996; Lopez-Meraz et al. 2005, 2007). Moreover, 
the administration of WAY100635, a 5-Ht1A antagonist, 
avoided the protective effect induced by the intrahippocam-
pal infusion of serotonin on the development of pilocar-
pine-induced seizures (Clinckers et al. 2004). therefore, 
these conflicting experimental evidence does not strongly 
support a potential therapeutic role for 5-Ht1ARs in tLE. 
On the other hand, compelling pre-clinical and human 
studies have indicated an impairment of 5-Ht1A signal in 
this form of focal epilepsy and comorbid psychiatric disor-
ders seen in these patients (theodore et al. 2012). Indeed, 
recent imaging studies have shown a reduced serotonin 
5-Ht1AR binding in temporal cortex and hippocampus of 
tLE patients (Giovacchini et al. 2005) that is correlated 
with scores on depression scales (theodore et al. 2007) and 
memory impairment (theodore et al. 2012). these findings 
are in agreement with the evidence that 5-Ht1A hypofunc-
tion induces hippocampal hyperexcitability (Chugani and 
Chugani 2003), reduces neoneurogenesis (Banasr et al. 
2004) and hippocampal functional integrity (Chugani and 
Chugani 2003) and impairs memory processes (Ogren et al. 
2008).
this work was proposed with the aim of clarifying the 
effect of 8-OH-DPAt in DG epileptogenesis using the in 
vivo  acute MDA model of reverberatory epileptic activity 
in the hippocampal–parahippocampal circuits (Stringer 
and Lothman 1992). the results obtained here are in disa-
greement with those in kindled rats (Cagnotto et al. 1998; 
Watanabe et al. 1998). Indeed, we observed that acute-
treated rats with 1 mg/kg of 8-OH-DPAt were resistant to 
the ‘kindling-like’ prolongation of electrographic seizure 
duration without affecting the time of onset of the parox-
ystic activity. It has been suggested that the latency to onset 
of MDA can be used as a gauge of seizure threshold; the 
duration of MDA can be used to measure of processes that 
terminate seizure activity in the limbic system. We found 
that systemic administration of 8-OH-DPAt produces a 
long-lasting effect (up to 4 h) similar to those obtained with 
conventional AEDs and MK-801 preventing the increase 
in duration of MDA, that is, kindling acquisition (Stringer 
and Lothman 1990a, b) but only partially suppressed kin-
dled after discharges (at the 19th stimulation which short-
ened the duration of the MDA already established, Fig. 2a). 
Insofar as (1) AED treatments that inhibit the lengthening 
of evoked after discharges (analogous to MDA) have been 
considered antiepileptogenic (White 2002), and (2) that 
blockade of the 5-Ht1AR before and after pilocarpine treat-
ment prevented seizure-induced hippocampal cell prolif-
eration and survival but not the development of mossy fibre 
sprouting or spontaneously recurring seizures (Radley and 
Jacobs 2003), we cannot consider the inhibition of MDA 
prolongation (Figs. 1, 2) to be consistent with an antie-
pileptogenic role for the 5-Ht1ARs. taken together, our 
results with previous findings suggest that 5-Ht1AR activa-
tion is mostly antiepileptic.
In addition to the seizure model, we investigated the 
effects of 8-OH-DPAt (1 mg/kg, i.p.) for an effect on excit-
ability, on paired-pulse interaction and on initiation of LtP 
in the DG with the aim of discovering the possible mecha-
nisms responsible for the anticonvulsant actions of this high 
dose of the drug. We found that 8-OH-DPAt affects most 
of these parameters in a complex and diverse way. First, we 
tested the effect of 8-OH-DPAt on the slope of the fEPSP 
and the amplitude of the pSpikes which increased both by 
about 20 % 15 min after its administration, less pronounced 
effects compared to the +60 % increase elicited by 25 and 
100 μg/kg of a previous early work (Klancnik et al. 1989). 
A possible explanation of our lower effects on population 
response is probably due to the fact that the high dose of 
8-OH-DPAt produces a mixed activation of pre- and post-
synaptic 5-Ht1ARs while low doses are selectively acting 
on the autoreceptors within the raphe neurons (Klancnik 
et al. 1989). Consistently, 8-OH-DPAt induced inhibition 
of population responses in a dose-dependent manner in the 
DG in vitro  (Klancnik et al. 1991) or when locally applied 
in the DG (Sanberg et al. 2006). Moreover, it is possible 
that high dose 8-OH-DPAt effects are mediated by the 
coactivation of 5-Ht7Rs, as recently results indicate this R 
subtype has a role in memory and hippocampal plasticity 
(Hedlund and Sutcliffe 2004; Costa et al. 2012a).
nonetheless, it can be excluded that our results are 
due to the sample size of our experimental group since 
we confirmed them in the LtP experiments where again 
we measured these variables for 30 min before the tetanic 
stimulation, obtaining consistent results (Fig. 6b, c). there-
fore, it seems that this high dose of 8-OH-DPAt produces 
a similar excitatory effect on basal activity at the PP syn-
apse and between the synapse and the spike-generating 
mechanism in the granular layer (Richter-Levin and Segal 
1990). We subsequently measured the reactivity of DG 
cells to increasing stimulation intensity of PP arising in 
the entorhinal cortex. there was no consistent shift of the 
stimulus intensity versus pSpike curve, stimulus intensity 
versus fEPSP slope curve or fEPSP slope versus pSpike 
amplitude (I/O) curve due to the drug treatment. these 
findings are surprising considering the excitatory effects 
seen in both the time course and the LtP experiments on 
slope and amplitude of pSpikes, possibly due to the differ-
ent stimulatory protocol or the time gap used for the I/O 
curves to assess the potency of synaptic connections. the 
inhibitory trend that we revealed in the pSpike amplitude 
in our I/O experiments is in agreement with previous obser-
vations with 0.2 mg/kg, i.p. of 8-OH-DPAt (Levkovitz 
and Segal 1997); nevertheless, in our conditions this effect 
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never reached statistical significance. Moreover, we con-
firmed the lack of effect of lower doses of 8-OH-DPAt on 
the slope of the fEPSPs when systemically applied (Levko-
vitz and Segal 1997). However, it has to be noted that local 
application of 10 nmol of 8-OH-DPAt in DG produced a 
reduction of about 50 % in the slope 30 min after its appli-
cation and a biphasical effect of pSpike amplitudes with 
a long-lasting decrease (Sanberg et al. 2006). Under our 
conditions, since that synaptic excitability is only slightly 
diminished in rats treated with a high dose of the drug, 
the likelihood that a cell will generate an action potential 
from a given synaptic drive remained unchanged (Fig. 3b). 
therefore, 1 mg/kg of 8-OH-DPAt seems to be ineffective 
in changing integration of synaptic inputs to produce a DG 
action potential.
We subsequently measured the level of PPI within 
the dentate. In a previous in vivo study, intra hippocam-
pal application of 8-OH-DPAt abolishes inhibition of the 
population spike observed in the second evoked response 
at intervals of 30–100 ms (Sanberg et al. 2006). In the 
present study, however, we observed different changes in 
paired-pulse relationships induced by its systemic admin-
istration. the triphasic pattern of paired-pulse interaction, 
illustrated in Fig. 5, is in full agreement with numerous 
earlier studies performed in the DG of rats anesthetized 
with urethane (Robinson and Racine 1986; Brucato et al. 
1992). no effects were seen for early and late inhibition 
(IPI between 20–25 and >600 ms) while after the PPR in 
animals treated with the anticonvulsant dose of 1 mg/kg 
of 8-OH-DPAt showed no sign of paired-pulse facilita-
tion (PPF) from the IPI of 40–150 ms although the differ-
ence was only significantly different for the two shorter 
intervals. notwithstanding, early paired-pulse inhibition 
was seen when 8-OH-DPAt was injected in the DG of 
freely moving animals (Sanberg et al. 2006). Our study is 
the first to demonstrate loss of facilitation of PP-evoked 
pSpike amplitude produced by systemic 8-OH-DPAt. PPF 
and depression of the pSpike can give useful information 
about feedforward and feedback inhibitory circuits in the 
hippocampus (Bliss et al. 2007). If the first stimulus of a 
pair is able to evoke a pSpike, a GABAA-mediated feed-
back inhibition lasting 10–20 ms prevents the second 
stimulus from evoking a pSpike. the spike facilitation 
at longer intervals may be explained by suppression of 
feedforward inhibition mediated by pre-synaptic GABAB 
autoreceptors (peak effect 100–200 ms). thus, one pos-
sible reason for decreased PPF in 8-OH-DPAt-treated 
animals is a stronger feedforward inhibition, which may 
result from partial inhibition of feedback interneurons. It 
is worth noticing that hilar interneurons in DG represent a 
population of feedback interneurons (Freund and Buzsaki 
1996) and express high levels of 5-Ht1ARs (Azmitia et al. 
1996) consistent with the evidence that serotonin inhibits 
hilar neurons (Misgeld et al. 1992), likely due to the acti-
vation of 5-Ht1ARs. Finally, to further evaluate the effect 
of the anticonvulsant dose of 8-OH-DPAt on hippocampal 
plasticity, we studied the PP-DG LtP induced by strong 
HSF. It is well known that the activation of 5-Ht1ARs by 
5-Ht is crucial for inducing LtP (Sanberg et al. 2006). In 
our condition, the drug pre-treatment induced a significant 
potentiation of the pSpike amplitude even when we sub-
tracted the baseline excitatory effect exerted by 1 mg/kg 
8-OH-DPAt, while the slope of the fEPSP was only 
slightly increased. It is noteworthy that systemic adminis-
tration of the 0.3 mg/kg of 8-OH-DPAt or its local appli-
cation in the MRn has been shown to attenuate dentate 
LtP induction while its injection in the DG was ineffec-
tive (Sanberg et al. 2006). this evidence suggests that the 
effect of 8-OH-DPAt must be mediated by the activation 
of 5-Ht1ARs external to the DG, for example, on raphe 
nuclei which are highly sensitive to 8-OH-DPAt (Jolas 
et al. 1995) and consequent reduction in the inhibitory 
5-Ht tone (Crespi 2010) on GABAergic interneurons. 
Moreover, activation of the 5-Ht1AR inhibits the induc-
tion of LtP in DG in slice preparation (Sakai and tanaka 
1993; Grzegorzewska et al. 2010). nevertheless, the dose 
of 8-OH-DPAt used in this study produced a clear-cut 
and significant increase in the LtP of the pSpike ampli-
tude; the exact mechanisms and brain sites through which 
this potentiation occurs obviously need further evaluation. 
It might be possible that with a high dose of 8-OH-DPAt, 
a stronger post-synaptic activation could be produced 
unmasking hyperpolarization of interneurons and reducing 
GABA release at the level of the PP-DG synapse. Moreo-
ver, the 5-Ht7 involvement cannot be excluded, although 
no data on its role on granular cells excitability are avail-
able yet.
Consistent with the relatively dense serotonergic inner-
vation of interneuron regions of the DG, the present study 
finds that 1 mg/kg of 8-OH-DPAt is anticonvulsant and 
reduces the MDA probably by an augmentation of interneu-
ron circuit activity. the principal findings of our study are 
that 8-OH-DPAt affects the reactivity and short- and long-
term plasticity of the PP-DG synapse, potentiating pSpike 
amplitude and the slope of fEPSP under normal condition 
and increased LtP through a possible 5-Ht1A mechanism. 
thus, our results suggest that 8-OH-DPAt at high dose 
might be useful not only in the control of epileptic seizures 
but also in the comorbid memory impairments which occur 
not infrequently in patients with epilepsy, especially with 
tLE (Bell et al. 2011). these positive cognitive effects 
together with the possible antidepressant properties of 
5-Ht1A agonists including 8-OH-DPAt (Lacivita et al. 
2008) and the antiepileptic activity shown here may offer 
new therapeutic possibilities (Lacivita et al. 2012) for an 
old drug.
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